Lord Trent Professor of Medicines and Health, Faculty of Science
I trained as an industrial pharmacist, was one of the first critical care specialist pharmacists in the UK, and gained a Department of Health funded PhD in health economics with Prof Martin Buxton (Health Economics Research Group, Brunel University). I have been in my current position since May 2007. Prior to this I was based at the School of Pharmacy, University of Manchester (1996 to 2007). In 2004, I won a Commonwealth Fund Harkness Fellowship to Harvard Medical School working with Prof Stephen Soumerai. Since 2006, I have been a member of the National Institute for Health and Clinical Excellence (NICE) Appraisal Committee, and a member of the Health Services Research Network (HSRN) Executive Board.
I co-ordinate the Health Economics At Nottingham (HER@N) group, which brings together and supports an expanding community of health economists within the University. I also co-ordinate the recently formed Pharmacy Economics Group, within DSRMH.
I am very familiar with communicating both health economics and clinical subjects to individuals or groups with little or no background in the area, using a wide range of teaching, learning and… read more
My research focus is the application of applied health economics and economic evaluation to medicines policy, prescribing and consumption. Specific themes are medicines adherence and safety and… read more
I am very familiar with communicating both health economics and clinical subjects to individuals or groups with little or no background in the area, using a wide range of teaching, learning and assessment methods. Twelve years experience of teaching health economics to undergraduate and postgraduate pharmacists and clinicians led to the writing of a textbook in health economics, which is now used as a recommended text in many British Schools of Pharmacy and was highly commended by Prof Alan Maynard.
My research focus is the application of applied health economics and economic evaluation to medicines policy, prescribing and consumption. Specific themes are medicines adherence and safety and quality of medicines use. Key current projects in these themes include:
* Adherence: NHS SDO Medicines for children: Partnerships with children and adolescents in medicine-taking: rights and responsibilities (PI: RAE, University of Nottingham) 03/08-09/10.(www.nottingham.ac.uk/pharmacy/TABS) * Safety and quality:
- · Patient Safety Research Programme The PINCER TRIAL: A cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices (PI: Prof. Anthony Avery, University of Nottingham) (www.pincertrial.org)
- · NIHR Connecting for Health: Evaluation of rollout of electronic transfer of prescriptions (London School of Economics (Tony Cornford), University of London School of Pharmacy (Nick Barber (PI), with Tony Avery, 2007-2010)
- · NIHR programme grant: Medical Crises in Older People (PI: John Gladman, University of Nottingham) May 2008-April 2013.
I use clinical trials, complex intervention cluster trials, observational data collection, systematic review and meta-analysis, quantitative handling of cost, cost effectiveness and net benefit data (principally non-parametric bootstrapping, regression and simulation techniques, probabilistic and Bayesian economic analysis techniques). My current expanding area of research is the use of administrative datasets to examine the economic impact of medicines related health policy, prescribing guidelines quality and patient medicines adherence, with four doctorate students working in this area. My Nottingham collaborations in this area include Prof Tony Avery (Division of Primary Care), Memberships of Committees & Professional Bodies
- · Royal Pharmaceutical Society of Great Britain (1989-present)
- · Editorial Board of Pharmacy World and Science (1995-present)
- · National Institute for Health and Care Excellence Appraisal Committee (2006-present)
- · UK Clinical Pharmacy Association (1990-present)
- · Health Economics Study Group (1992-present)
- · International Health Economics Association (1992-present)
- · Academic Pharmacy Group (2001-present)• Society for Medical Decision-Making (2002-present)
- · International Society of Pharmacoeconomics and Outcomes Research (ISPOR) (2004-present)
- · NICE Patient Safety Advisory Committee (2007-2009)
- · Health Services Research Network Executive Board (2007-present)